ArticleCancer medicine2019

Resveratrol promotes sensitization to Doxorubicin by inhibiting epithelial-mesenchymal transition and modulating SIRT1/β-catenin signaling pathway in breast cancer.

Xiaoxia Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.